Literature DB >> 7091230

The relationship of genital tract actinomycetes and the development of pelvic inflammatory disease.

R Burkman, S Schlesselman, L McCaffrey, P K Gupta, M Spence.   

Abstract

As a corollary to a case-control study evaluating the risk of pelvic inflammatory disease (PID) among users of an intrauterine contraceptive device (IUD), Papanicolaou smears were studied to detect the presence of actinomycetes. Forty-six PID case patients and 108 control patients were included in the corollary study. The presence of actinomycetes was noted only among current or past wearers of an IUD. Women with actinomycetes present on Papanicolaou smear had a 3.6-fold risk of hospitalization for PID, as compared to women without actinomycetes. This trend persisted when only IUD users were evaluated. Of patients with PID who had actinomycetes noted on the Papanicolaou smear, 87 1/2% had a tuboovarian abscess, compared to 28.9% of patients without actinomycetes. In addition, patients with actinomycetes present had PID treated surgically more frequently.

Entities:  

Keywords:  Abortion History; Adnexitis--etiology; Age Factors; Contraception; Contraceptive Methods--complications; Contraceptive Usage; Diseases; Ethnic Groups; Examinations And Diagnoses; Family Planning; Infections; Iud--complications; Marital Status; Measurement; Pelvic Infections; Pelvic Inflammatory Disease; Population Characteristics; Prevalence; Reproductive Tract Infections; Research Methodology; Sex Behavior; Sexually Transmitted Diseases

Mesh:

Year:  1982        PMID: 7091230     DOI: 10.1016/0002-9378(82)90552-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Recurrent extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infection due to an infected intrauterine device.

Authors:  Chee-Kin Hui
Journal:  Singapore Med J       Date:  2014-02       Impact factor: 1.858

2.  Actinomyces israelii may produce vulvar lesions suspicious for malignancy.

Authors:  Jennifer Y McElroy; Marsha E Gorens; Lisa N Jackson; Danielle Stigger; Teresa Becker; Eyal Sheiner
Journal:  Infect Dis Obstet Gynecol       Date:  2006

3.  Ultrasound-guided transvaginal aspiration in the management of actinomyces pelvic abscess.

Authors:  E Y Anteby; G Rahav; J Hanoch; S Shimonovitz; S Yagel; N Laufer
Journal:  Infect Dis Obstet Gynecol       Date:  1996

4.  A case of ovarian actinomycosis.

Authors:  Masahiro Iwasaki; Akira Nishikawa; Noriyuki Akutagawa; Takashi Fujimoto; Mizue Teramoto; Ryuichi Kudo
Journal:  Infect Dis Obstet Gynecol       Date:  2003

5.  Management of intrauterine device-associated actinomycosis.

Authors:  A Chatwani; S Amin-Hanjani
Journal:  Infect Dis Obstet Gynecol       Date:  1993

6.  Five-year review of copper T intrauterine device use at the University of Calabar Teaching Hospital, Calabar.

Authors:  Christopher U Iklaki; Anthony U Agbakwuru; Atim E Udo; Sylvester E Abeshi
Journal:  Open Access J Contracept       Date:  2015-10-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.